Artemio Capili Santiago, MD | |
5409 Ave O, Suite 107, Fort Madison, IA 52627-9601 | |
(319) 372-7270 | |
(319) 372-7279 |
Full Name | Artemio Capili Santiago |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 5409 Ave O, Fort Madison, Iowa |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376510883 | NPI | - | NPPES |
13885 | Medicaid | IA | |
421324159 | Other | HUMANA GOLD | |
421324159 | Other | UNITED HEALTH CARE | |
42132415901 | Other | JOHN DEERE HEALTH CARE | |
421324159 | Other | WAUSAU | |
421324159 | Other | AETNA | |
421324159 | Other | STANDARD LIFE | |
421324159 | Other | APWU | |
793111317 | Other | IA | PALMETTO GBA |
421324159 | Other | BANKERS LIFE & CASUALTY | |
421324159 | Other | NATL ASSC LETTER CARRIERS | |
421324159 | Other | TRI CARE | |
13885 | Other | WELLMARK BCBS IA | |
421324159 | Other | SECURE HORIZONS | |
421324159T | Other | BLUE SHIELD OF ILLINOIS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 20740 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Artemio Capili Santiago, MD 5409 Ave O, Suite 107, Fort Madison, IA 52627 Ph: (319) 372-7270 | Artemio Capili Santiago, MD 5409 Ave O, Suite 107, Fort Madison, IA 52627-9601 Ph: (319) 372-7270 |
News Archive
More than a hundred candidate vaccine trials against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), are underway. About 35 are now undergoing clinical evaluation, and of these, nine are in the final phase of human trials, including the vaccine developed by Oxford University and the biopharmaceutical firm, AstraZeneca.
The Washington Post examines access to maternal and child health services in Sierra Leone after the government dropped fees for such services last year, a move that "appears to have sharply cut into mortality rates for pregnant women and deaths from malaria for small children."
An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial clearance and reduce hearing loss, according to researchers at Georgia State University and the University of Rochester.
Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.
Massachusetts' 2009 ban on ambulance diversion not only did not increase emergency department length of stay or ambulance turnaround time but may actually have led to improvements in both areas, according to a study published online today in Annals of Emergency Medicine ("The Effect of an Ambulance Diversion Ban on Emergency Department Length of Stay and Ambulance Turnaround Time").
› Verified 3 days ago
Dr. Pauline Mungai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 | |
Roseller Libarnes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 Fax: 319-376-2188 | |
Dr. Victoria Kogan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 Fax: 319-376-2188 | |
Lisa Bishop, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5409 Avenue O, Fort Madison, IA 52627 Phone: 319-376-2134 Fax: 319-376-2188 |